Bailey Jeffrey Allen bought AUPH
June 4, 2026 · Form 4 insider transaction
Bailey Jeffrey Allen bought 23,931 shares of Aurinia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
23,931
Price
$0.00
Total value
N/A
InsiderBailey Jeffrey Allen
Role—
SecurityDirector Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 4, 2026
Filing dateJune 8, 2026
Shares owned after23,931
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options shall vest one year from date of grant.